Fig. 7From: Role of interim positron emission tomography/computed tomography in assessment of lymphoma treatment responseMale patient, 48 years old, diagnosed of HD (mixed cellularity) received different lines of chemotherapy then underwent autologous bone marrow transplant followed by radiotherapy, after 10 years; he developed weight loss and elevated serum LDH. His international prognostic risk category was high-intermediate risk. First post-transplant PET/CT (hepatic reference 1.7) axial CT (A & C) and axial fused PET/CT (B & D) images show metabolically active subcarinal LN (white arrows) measuring about 3.2 × 1.9 cm and achieving SUVmax 3 & metabolically active bilateral inguinal LNs (yellow arrows), the largest measuring about 9 mmm in short axis and achieving SUVmax 8.4. FNAC from right external iliac LNs was done confirming the relapse. The patient received 3 cycles chemotherapy. Second post-transplant PET/CT (hepatic reference 2.7) axial CT (A & C) and axial fused PET/CT (B & D) images show morphological and metabolic stationary course of the subcarinal (white arrows) and bilateral inguinal (yellow arrows) LNs. It was reported as stable disease with Deauville score 4Back to article page